Why the study?
Radiation-induced acute pericarditis is a rare but life-threatening condition that requires prompt recognition.
Highlights the need for early recognition of radiation-induced pericarditis in patients receiving concurrent thoracic radiation and osimertinib.
Answers are grounded in this paper and cite their sources.
Acute pericarditis may occur immediately after palliative radiation in Osimertinib-treated NSCLC; this Level 5 case leaves open a potential interaction.
Radiation-induced acute pericarditis is a rare but life-threatening condition requiring prompt recognition. We report a case of acute pericarditis occurring immediately after palliative spine radiation in a 54-year-old male with non-small cell lung cancer (NSCLC) on Osimertinib. He initially presented with brain, liver, spleen, and bone metastases and was treated with erlotinib and whole-brain radiation. Disease progression prompted a switch to Osimertinib and palliative spine radiation for spinal cord compression. Two days post-radiotherapy, he developed acute chest pain, diagnosed as radiation-induced pericarditis, possibly exacerbated by Osimertinib. Symptoms improved with aspirin and colchicine, and Osimertinib was safely resumed. This case highlights the importance of early recognition of radiation-induced pericarditis, particularly in patients receiving concurrent thoracic radiation and Osimertinib, to ensure timely management and prevent complications.
No takes yet. Share an insight, caveat, or question.
Decha-Umphai et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: